Market Share of Latin America Glucagon-like Peptide-1 (GLP-1) Agonists Industry
The Latin America glucagon-like peptide-1 (GLP-1) agonists market is consolidated, with a few major manufacturers like Eli Lilly, AstraZeneca, Merck, Boehringer Ingelheim, and Novartis, etc. gaining presence in major countries while the remaining market comprises other local or region-specific manufacturers.
Latin America Glucagon-like Peptide-1 Agonists Market Leaders
-
AstraZeneca
-
Biocon
-
Novo Nordisk A/S
-
Eli Lilly and Company
-
Sanofi Aventis
*Disclaimer: Major Players sorted in no particular order